Drug Profile
Hib vaccine conjugate - Panacea Biotec
Alternative Names: Haemophilus influenzae type B vaccine - Panacea Biotech; novoHibLatest Information Update: 28 Sep 2021
Price :
$50
*
At a glance
- Originator Panacea Biotec
- Class Conjugate vaccines; Haemophilus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Haemophilus infections
Most Recent Events
- 28 Sep 2021 Discontinued - Preregistration for Haemophilus infections in Russia (IM)
- 03 May 2016 No recent reports on development identified - Preregistration for Haemophilus infections in Russia (IM)
- 31 Jul 2012 Hib vaccine conjugate licensed to Binnopharm in Russia